US FDA approves prevention of preterm birth

The United States Food and Drug Administration (FDA) has approved Aspen Pharmacare, a drug that can be used to prevent preterm birth in pregnant women, Reuters reported.

The basis of the new drug is hydroxyprogesterone caproate (HPC).

Aspen got the FDA abbreviated new drug application approval in early August for a preservative-free, single-dose vial, Chief Executive Stephen Saad said at the pharmaceutical’s annual result presentation.

Aspen, which operates in approximately 56 countries, previously stated that it plans to work more actively in the US market by providing its niche products for women's health, such as conjugated estrogens, which are used in hormone replacement therapy for menopause.